학력 Education
1987. 02 부산대학교 약학대학 제약학과 학사
1989. 02 부산대학교 대학원 제약학과 석사
1997. 09 부산대학교 대학원 약학박사
경력 Experience
1990 - 1992 부산대학교 약학대학 조교
1999 - 2004 National Institute of Health, National Cancer Institute, Department of Cell and Cancer Biology, Postdoctoral fellow
2004 - 2008 부산대학교 약학대학 약학부 조교수
2008 - 2013 부산대학교 약학대학 약학부 부교수
2013.3 - 현재 부산대학교 약학대학 약학부 교수
연구업적 Achievements
1. Kim H, Huh J, Jeon H, Choi D, Han J, Kim Y, Jung Y. N,N`-Bis(5-aminosalicyl)-L-cystine is a potential colon-specific 5-aminosalicylic acid prodrug with dua therapeutic effects in experimental colitis. J Pharm Sci. 2008 Apr 9. [Epub ahead of print]
2. Kim H, Kim D, Choi D, Jeon H, Han J, Jung Y, Kong H, Kim YM Synthesis and properties of N,N`-bis(5-aminosalicyl)-L-cystine as a colon-specific deliverer of 5-aminosalicylic acid and cystine. Drug Deliv2008 Jan, 15(1), 37-42.
3. Jung YJ and Kim YM, Evaluation of cellulose xanthate-metal-tetracycline complexes as a polymeric antibacterial agent with prolonged antibacterial activity, Drug Deliv 2008 Jan,15(1), 31-35.
4. Jeon H, Kim H, Choi D, Kim D, Park SY, Kim YJ, Kim YM, Jung Y, Quercetin activates an angiogenic pathway HIF-1-VEGF by inhibiting HIF-prolyl hydroxylase: A structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase, MOLECULAR PHARMACOLOGY 2007 Jul; 71(6) 1676-1684.
5. Lee J, Rho J, Yang Y, Kong H, Jung Y, Kim Y., Synthesis and in vitro evaluation of N-nicotinoylglycyl-2-(5-fluorouracil-1-yl)-d,l-glycine as a colon-specific prodrug of 5-fluorouracil, J Drug Target, 2007 Apr; 15(3), 199-205,
6. Yang YW, Lee JS, Kim I, Jung YJ, Kim YM., Synthesis and properties of N-nicotinoyl-2-(5-fluorouracil-1-yl)-d,l-glycine ester as a prodrug of 5-fluorouracil for rectal administration, Eur J Pharm Biopharm, 2007 Apr; 66(2), 260-267
7. Yunjin Jung, Wanping Xu, Heejung Kim, Namchul Ha and Len Neckers Curcumin-induced degradation of ErbB2: A role for the E3 ubiquitin ligase CHIP and the Michael reaction acceptor activity of curcumin. Biochim Biophys Acta, 2007 Mar; 1773(3), 383-390